MR-ICP: Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure

Sponsor
University of Miami (Other)
Overall Status
Recruiting
CT.gov ID
NCT03212976
Collaborator
(none)
30
2
2
73.2
15
0.2

Study Details

Study Description

Brief Summary

This study is designed to evaluate the accuracy of a non-invasive method phase-contrast magnetic resonance imaging (MR-ICP) for assessing intracranial pressure (Phase 1).

To perform second phase contrast imaging to evaluate the patency and flow of ventricular catheters after MR-ICP imaging (Phase 2).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Phase contrast magnetic resonance imaging
N/A

Detailed Description

The study will be divided into 2 phases. In Phase 1, patients with an intracranial pressure monitor will be recruited to the study, while in Phase 2, patients with shunts or Cerebral Spinal Fluid (CSF) access devices (Ommaya, reservoir, etc.) will be eligible for the study.

Two separate groups of patients will be recruited to each phase of the study. Each phase of the study will involve MR-ICPs. The MR-ICP is an extra 5-10 minute sequence at the end of a MRI that assesses the pressure in the head. The MRI will take scans of the brain during different phases of the cardiac cycle and will assess the volume changes while the patient is lying flat. The pressure in the head will be estimated based on these calculations. This estimate will be compared to the pressure in the head as determined by the ICP monitor.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Assessment of the Clinical Efficacy of a Non-Invasive Measurement of Intracranial Pressure by Magnetic Resonance Phase Contrast Imaging
Actual Study Start Date :
Oct 26, 2017
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Study Phase 1

Patients with an intracranial pressure monitor will undergo phase contrast magnetic resonance imaging to measure their ICP.

Procedure: Phase contrast magnetic resonance imaging
Phase-contrast magnetic resonance imaging will be done to assess intracranial pressure

Other: Study Phase 2

Patients with shunts or CSF access devices such as Ommaya reservoir, etc will undergo phase contrast magnetic resonance imaging

Procedure: Phase contrast magnetic resonance imaging
Phase-contrast magnetic resonance imaging will be done to assess intracranial pressure

Outcome Measures

Primary Outcome Measures

  1. Intracranial Pressure Measurement [1 day]

    Ratio of intracranial volume

  2. Patency of ventricular catheters [7 days]

    Patency of ventricular catheters will be measured using multi-voxel MRI-ICP to qualitatively assess presence of CSF flow.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients referred for a MRI by Attendings in the Department of Neurological Surgery at the University of Miam with intracranial pathology with external ventricular drains (EVDs) or intracranial bolts placed for hydrocephalus or intracranial hypertension. Bolts must be placed prior to enrollment in the study to avoid any alterations in standard procedure

  • All pathological entities that produce intracranial hypertension will be included (trauma, tumor, vascular, infectious, inflammatory, etc).

  • Patients must undergo a MRI for another clinically indicated reason (diagnosis, surveillance, cervical MRI clearance, prognosis, etc).

  • English and Spanish-speaking patients

Exclusion Criteria:
  • Unable to obtain MRI due to prior implants, metallic material, inability to sit still

  • Refractory intracranial hypertension (not controlled with medications, surgery, or EVD)

  • Unable to obtain informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jackson Memorial Hospital Miami Florida United States 33136
2 University of Miami Hospital Miami Florida United States 33136

Sponsors and Collaborators

  • University of Miami

Investigators

  • Principal Investigator: Ronald Benveniste, MD, PhD, University of Miami

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ronald Benveniste, Associate Professor, University of Miami
ClinicalTrials.gov Identifier:
NCT03212976
Other Study ID Numbers:
  • 20170130
First Posted:
Jul 11, 2017
Last Update Posted:
Nov 17, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ronald Benveniste, Associate Professor, University of Miami
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 17, 2021